Number of pages: 100 | Report Format: PDF | Published date: March 21, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
Report Attribute |
Details |
Market Size Value in 2022 |
US$ 1.7 billion |
Revenue Forecast in 2031 |
US$ 2.8 billion |
CAGR |
5.2% |
Base Year for Estimation |
2022 |
Forecast Period |
2023-2031 |
Historical Year |
2021 |
Segments Covered |
Volume, End User, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global RNase- and DNase-free pipette tips market was valued at US$ 1.7 billion in 2022 and is expected to register a revenue CAGR of 5.2% to reach US$ 2.8 billion by 2031.
RNase- and DNase-free Pipette Tips Market Fundamentals
RNase- and DNase-free pipette tips are single-use, autoclavable accessories used with pipettes to take in and dispense liquids. Several laboratories make use of micropipettes for research purposes. Pipette tips can be used in research or diagnostic labs to distribute liquids into a well plate for polymerase chain reaction (PCR) testing and performing several assays. Microbiology labs also use micropipette tips to test industrial products for dispensing testing materials. Each tip has a different maximum microliter capacity, ranging from 0.01µL to 5mL. The clear, plastic-molded pipette tips are designed to make it simple to see the contents. The researcher needs to buy sterile or non-sterile, filtered, or unfiltered micropipette tips, and they should all be devoid of DNase, RNase, DNA, and pyrogen. DNases and RNases are nucleases that perform the enzymatic DNA and RNA breakdown. PCR is becoming increasingly popular as the industry standard for identifying and characterizing microorganisms and genetic markers in various sample types. Unfortunately, the approach is vulnerable to inhibitory compounds like DNase and RNase- that can be present in the sample under analysis, which could decrease the assay’s sensitivity or possibly result in false-negative results. Therefore, the equipment and plastic wares should be DNase and RNase- free during the experiments to avoid contamination.
[67876]
RNase- and DNase-free Pipette Tips Market Dynamics
The increasing prevalence of genetic abnormalities and infectious diseases and increased research and development efforts in the life sciences sector drive the revenue growth of the RNase- and DNase-free pipette tips market. The increased burden of infectious diseases and genetic disorders is fueling market expansion. For instance, a survey by the World Health Organization found that between January 24 and February 6, 2022, 12,368 people tested positive for influenza viruses, of which 8,423 (68.1%) had influenza A, and 3,945 (31.9%) had influenza B. 171 (6.4%) of the sub-typed influenza A viruses were influenza A (H1N1) pdm09, and 2,483 (93.6%) were influenza A viruses (H3N2). Additionally, the expanding use of clinical diagnostics, increased demand for individualized and precision medicine, and the use of technology and applications in drug development influence the increased research and development globally. A major area of study for molecular biology is the genetic diversity and relationships of people, animals, and plants. Many molecular studies are carried out to deal with different cell types, DNA, and its manifestations. The newly expanding study has a lot of room for further investigation in agriculture, animal model research, medicine, and other relevant topics. Throughout the pipette tips market projection period, rising molecular biology demand is anticipated to impact market revenue growth positively. Also, biotechnology companies worldwide attempt to create revolutionary products and solutions to treat ailments without making errors. Future market revenue growth is also expected to be fueled by increased investment in R&D activities, technological advancements in the healthcare sector, and improved healthcare infrastructure.
To execute experiments more efficiently and correctly, RNase- and DNase-free pipette tips are utilized in research. As a result, a greater emphasis on advancing research to enhance patient health is fueling market expansion. The frequency of diagnostic testing and screening was increased in 2020 due to constrained manufacturing and distribution channels. Also, there was a shortage of pipette tips due to trade restrictions restricting imports and exports. Pipette tips cannot be reused since they are disposed of to prevent cross-contamination. For effective screening of large quantities, it has been observed that RNase- and DNase-free pipette tip production capacity is expanding, which promotes market growth. The need for RNase- and DNase-free pipette tips is rising as more individuals become aware of the importance of clean, labeled, and contaminant-free products. The market share for RNase- and DNase-free pipette tips is expanding due to a rise in processed and packaged food consumption in developed nations and a shift in convenience food consumption in developing and emerging economies. RNase- and DNase-free Pipette tips are used increasingly frequently in research and development, although automated pipettes are replacing manual pipettes as the number of samples for analysis rises. Laboratories can lower the cost of reagents and samples by continuing to produce smaller medical equipment and devices.
However, alternative flooring options and high prices are anticipated to restrain global market revenue growth. In addition, growing labor prices and a lack of reasonably priced, skilled personnel in some nations are projected to restrain market revenue growth over the coming years.
RNase- and DNase-free Pipette Tips Market Ecosystem
The global RNase- and DNase-free pipette tips market is analyzed from three perspectives: volume, end user, and region.
RNase- and DNase-free Pipette Tips Market by Volume
[95656]
Based on the volume, the global RNase- and DNase-free pipette tips market is segmented into 10 µL, 200 µL, 1000 µL, and others.
The 200 µL segment accounted for the largest revenue share of the global RNase- and DNase-free pipette tips market in 2022. The 20-200 µL range pipette tips are frequently used for laboratory molecular biology and microbiology experiments. In molecular biology and biochemistry, PCR has a wide range of uses, including the analysis of gene expression, the identification of mutations, forensic analysis, and pathogen detection. Many laboratories use quantitative real-time PCR to assess copy counts from total yield. By identifying specific genetic variants or disease-related biomarkers, PCR in companion diagnostics might help clinicians determine the optimal course of treatment for each patient. For performing PCR, the basic requirement is the reagent preparation and sample delivery. For that purpose, 200 µL pipette tips are the most important fundamental plastic ware used for sample preparation and loading. On the other hand, different molecular experiments, including PCR, molecular cloning DNase, and RNase- free tips, are necessary.
RNase- and DNase-free Pipette Tips Market by End User
Based on the end user, the global RNase- and DNase-free pipette tips market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and others.
The pharmaceutical and biotechnology companies segment accounted for the largest revenue share of the global RNase- and DNase-free pipette tips market in 2022. The development of patient-centric approaches has been made possible by the field of personalized modern medical ongoing advancements, which have created multiple opportunities to treat various medical conditions, further influencing the increased research activities. Due to this advancement, smaller batches rather than larger ones are now used to develop sophisticated medications and autologous patient-centered therapies. Thus, multiple experiments are performed in the pharmaceutical and biotechnology industries for large-scale research and development. Also, the processes used in drug production are anticipated to be stimulated by an increase in drug approvals by regulatory organizations. Moreover, a significant number of active clinical trials have produced many market expansion prospects.
Major pharmaceutical corporations, such as Merck and Eli Lilly, produced new antibiotics, vaccines, and drugs that drastically improved people’s lives. Nowadays, however, pharmaceutical sector innovation is completely different. The demand for pipette tips has increased with the upsurge in research and development activities. Assays using cells and molecules are essential for creating new therapeutic compounds. Cell-based assays, biochemical tests, and genetic screening are all utilized to assess the target and interference cell components. The understanding of the binding and target substances is made possible by molecular biology. The molecular pathways aid in the identification of the target proteins. Thus, research based on molecular biology is the most important factor playing a crucial role in the pharmaceutical and biotechnology industry. Increased application of molecular biology is the major driving force for the global RNase- and DNase-free pipette tips market in the pharmaceutical and biotechnology industries.
RNase- and DNase-free Pipette Tips Market by Region
Based on the region, the global RNase- and DNase-free pipette tips market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounted for the largest revenue share of the global RNase- and DNase-free pipette tips market in 2022. Favorable government policies, the introduction of new and cutting-edge products, significant investment in the biotechnology industry, and a rise in product demand are the main market-driving factors. Robust funding through alliance investment in start-up biotechnology companies for implementing new and cutting-edge products also contributes to market revenue growth. For instance, through Illumina Accelerator, Illumina, Inc. invested in nine new genomics start-ups in February 2021, including four start-ups in the United Kingdom and five in the United States. Many elements, including major competitors, considerable R&D efforts, and high healthcare expenditures, can be attributed to the expansion of the regional market. Also, several regional businesses are gaining medicinal approvals, fostering market expansion. Because even a single regulatory permission might grant access to the entire region, the area is strategically crucial for distributing pipette tips. In addition, the governments spend more per person on healthcare than developing nations do, which promotes the expansion of the medical device sector.
The Asia Pacific region also accounted for the second largest revenue share of the global RNase- and DNase-free pipette tips market. Clinical trial services, supportive government regulations, expanding healthcare infrastructure, and epidemiological considerations can all be credited with developing the regional market. Also, to speed up the expansion of the biotechnology industry, international businesses work closely with local businesses.
RNase- and DNase-free Pipette Tips Market Competitive Landscape
Due to product launches, mergers, and acquisitions, the global RNase- and DNase-free pipette tips market is highly competitive. Some primary development strategies that many organizations prioritize include introducing novel materials, securing approval for those goods, and taking part in additional initiatives. Moreover, the market categorized partnerships, acquisitions, and numerous other forms of collaboration as better revenue growth strategies. With the expanding global market demand for RNase- and DNase-free pipette tips, these actions have raised the prospects for profitable revenue growth in the future.
Notable market participants include:
RNase- and DNase-free Pipette Tips Market Strategic Developments
Pipette tips are disposable, sterilizable attachments that can disperse liquids using a pipette. RNase- and DNase-free pipette tips are specially sterilized to eliminate nucleases, which can hinder the quality and result of molecular biology experiments.
Increased application of molecular biology and enhanced research and development fuel the revenue growth of the global RNase- and DNase-free pipette tips market.
The lack of trained personnel and the chances of high nucleic acid contamination hinder the revenue growth of the global RNase- and DNase-free pipette tips market.
Thermo Fisher Scientific, Inc., Eppendorf, Analytik Jena GmbH, Corning Incorporated, and INTEGRA Holding AG are key companies operating the global RNase- and DNase-free pipette tips market.
The global RNase- and DNase-free pipette tips market is expected to grow at a revenue CAGR of 5.2% during the forecast period from 2023 to 2031.
*Insights on financial performance are subject to the availability of information in the public domain